A study on outcome of children with dengue infection and its clinical correlation with hepatidysfunction in a tertiary care hospital of Saurashtra
DOI:
https://doi.org/10.18203/2349-3291.ijcp20250406Keywords:
Pediatric dengue, Hepatic dysfunction, Dengue serology, Liver enzymesAbstract
Background: Dengue infection in children can significantly impact hepatic function, yet the spectrum of liver involvement and its correlation with disease severity needs further exploration in pediatric populations.
Methods: A prospective observational study was conducted from July 2023 to July 2024 at a Guru Gobindsingh Government Hospital, Jamnagar in Saurashtra region, including 95 children aged 2 months to 12 years with suspected or confirmed dengue. Clinical assessments, dengue serology (NS1 antigen, IgM & IgG antibodies), liver function tests, coagulation profile, and complete blood counts were performed. The study evaluated hepatic dysfunction parameters and their correlation with disease severity.
Results: Males and the 6-10 years age group were predominantly affected. Fever and petechial rash were the most common presentations. Laboratory findings revealed thrombocytopenia (67.3%), elevated total serum bilirubin (33.3%), raised SGPT (53.75%), elevated INR (6.3%), and low serum albumin (26.3%). Disease classification showed DF (87.4%), DHF (11.6%), and DSS (1.1%). The mortality rate was 1.1%, with one death due to DSS.
Conclusions: Hepatic dysfunction in pediatric dengue presents a broad spectrum from mild enzyme elevation to severe hepatic failure. Significant liver enzyme elevation correlates with severe dengue manifestations. Seropositivity is associated with increased hepatic dysfunction and disease severity, emphasizing the importance of liver function monitoring in dengue management.
Metrics
References
Zhang SX, Yang GB, Zhang RJ, Zheng JX, Yang J, Lv S, et al. Global, regional, and national burden of dengue, 1990–2021: Findings from the global burden of disease study 2021. Decoding Infect Transm. 2024;2:100021. DOI: https://doi.org/10.1016/j.dcit.2024.100021
Kalayanarooj S. Clinical manifestations and management of dengue/dhf/dss. Tropical Medicine and Health. 2011;39(4):83-7. DOI: https://doi.org/10.2149/tmh.2011-S10
Roy A, Sarkar D, Chakraborty S, Chaudhuri J, Ghosh P, Chakraborty S. Profile of hepatic involvement by dengue virus in dengue infected children. North American J Med Sci. 2013;5(8):480. DOI: https://doi.org/10.4103/1947-2714.117313
Thach TQ, Eisa HG, Hmeda AB, Faraj H, Thuan TM, Abdelrahman MM, et al. Predictive markers for the early prognosis of dengue severity: A systematic review and meta-analysis. PLoS neglected tropical diseases. 2021;15(10):9808. DOI: https://doi.org/10.1371/journal.pntd.0009808
Huy BV, Toàn NV. Prognostic indicators associated with progresses of severe dengue. PloS one. 2022;17(1):262096. DOI: https://doi.org/10.1371/journal.pone.0262096
Moras E, Achappa B, Murlimanju BV, Raj GN, Holla R, Madi D, et al. Early diagnostic markers in predicting the severity of dengue disease. 3 Biotech. 2022;12(10):268. DOI: https://doi.org/10.1007/s13205-022-03334-9
Moallemi S, Lloyd AR, Rodrigo C. Early biomarkers for prediction of severe manifestations of dengue fever: a systematic review and a meta-analysis. Scientific Reports. 2023;13(1):17485. DOI: https://doi.org/10.1038/s41598-023-44559-9
Prasad D, Bhriguvanshi A. Clinical profile, liver dysfunction and outcome of dengue infection in children: a prospective observational study. The Pediatric Infec Disease J. 2020;39(2):97-101. DOI: https://doi.org/10.1097/INF.0000000000002519
Srivastava G, Chhavi N, Goel A. Validation of serum aminotransferases levels to define severe dengue fever in children. Pediatric Gastroenterol, Hepatol Nutr. 2018;21(4):289-96. DOI: https://doi.org/10.5223/pghn.2018.21.4.289
Jagadishkumar K, Jain P, Manjunath VG, Umesh L. Hepatic involvement in dengue Fever in children. Iran J Pediatr. 2012;22(2):231-6.
Lee L, Gan V, Lee V, Tan A, Leo Y, Lye D. Clinical relevance and discriminatory value of elevated liver aminotransferase levels for dengue severity. PLoS Neglected Tropical Diseases. 2012;6(6):1676. DOI: https://doi.org/10.1371/journal.pntd.0001676
Mohan B, Patwari A, Anand V. Brief report. hepatic dysfunction in childhood dengue infection. J Tropical Ped. 2000;46(1):40-3. DOI: https://doi.org/10.1093/tropej/46.1.40
Alam R, Fathema K, Yasmin A, Roy U, Hossen K, Rukunuzzaman M. Prediction of severity of dengue infection in children based on hepatic involvement. JGH Open. 2024;8(3):56. DOI: https://doi.org/10.1002/jgh3.13049
Giri S, Anirvan P, Vaidya A, Praharaj DL. Dengue-related acute liver failure-A scoping review [published correction appears in Indian J Gastroenterol. 2024;43(3):695. DOI: https://doi.org/10.1007/s12664-024-01622-1
Pancharoen C. Coinfections in dengue patients. The Pediatric infectious Dis J. 1998;17(1):81-2. DOI: https://doi.org/10.1097/00006454-199801000-00019
Soundravally R, Narayanan P, Bhat BV, Soundraragavan J, Setia S. Fulminant hepatic failure in an infant with severe dengue infection. The Indian J Ped. 2010;77:435-7. DOI: https://doi.org/10.1007/s12098-010-0027-z
Vega R, Phumratanaprapin W, Phonrat B, Dhitavat J, Sutherat M, Choovichian V. Differences in liver impairment between adults and children with dengue infection. The Am Soc Trop Med and Hyg. 2016;94(5):1073-9. DOI: https://doi.org/10.4269/ajtmh.15-0507
Downloads
Published
How to Cite
Issue
Section
